 effect surgic menopaus estrogen replac cytokin releas human blood mononuclear cell mononuclear cell secretori product chang bone turnov develop postmenopaus osteoporosi effect oophorectomi subsequ estrogen replac spontan secret interleukin tumor necrosi factor alpha tnf-alpha phytohemagglutinin a-induc secret granulocyte-macrophag colony-stimul factor gm-csf peripher blood mononuclear cell healthi premenopaus women underw oophorectomi increas gm-csf activ earli week surgeri wherea elev tnf-alpha hydroxyproline/creatinin calcium/creatinin ratio urinari indic bone resorpt detect week surgic procedur oophorectom women estrogen therapi surgeri subject hydroxyproline/creatinin calcium/creatinin ratio week cytokin level week oophorectomi studi women estrogen replac therapi week oophorectomi indic bone resorpt decreas secret cytokin level week therapi women estrogen therapi osteocalcin marker bone format preoper level week oophorectomi wherea estrogen-tr subject unchang entir studi period femal control simpl hysterectomi cytokin releas biochem indic bone turnov chang surgeri data chang estrogen statu vivo secret mononuclear cell immun factor vitro alter local product bone-act cytokin chang bone turnov menopaus estrogen replac